Volpara Health
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
This marks the fourth clearance for Volpara’s breast health platform since its original authorization back in 2010.
Volpara is purchasing all outstanding equity of CRA for $18 million and will pay an additional $4 million if certain strategic targets are met within 18 months.